Endoscopic Management of Barrett's Esophagus with High-Grade Dysplasia and Early-Stage Esophageal Adenocarcinoma

Thoracic Surgery Clinics

Volumn 23, Issue 4, 2013, Pages 479-489

  Davila, Marta L ^a   Hofstetter, Wayne L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cryotherapy; Dysplasia; Endoscopic mucosal resection; Esophagectomy; Intestinal metaplasia; Radiofrequency ablation

Indexed keywords

LIQUID NITROGEN; LOCAL ANESTHETIC AGENT; SUCRALFATE;

ARGON PLASMA COAGULATION; AUTOFLUORESCENCE IMAGING; BARRETT ESOPHAGUS; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CHROMOENDOSCOPY; CONFOCAL LASER MICROSCOPY; CRYOTHERAPY; DIAGNOSTIC ACCURACY; DISEASE SURVEILLANCE; DYSPLASIA; ENDOSCOPE; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SUBMUCOSAL DISSECTION; ENDOSCOPIC THERAPY; ENDOSCOPIST; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; ESOPHAGUS HEMORRHAGE; ESOPHAGUS PERFORATION; ESOPHAGUS RESECTION; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HIGH GRADE DYSPLASIA; HIGH RESOLUTION ENDOSCOPY; HUMAN; INTESTINE METAPLASIA; LYMPH VESSEL METASTASIS; MULTICENTER STUDY (TOPIC); NARROW BAND IMAGING; ODYNOPHAGIA; PHOTODYNAMIC THERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION INJURY; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; SENSITIVITY ANALYSIS; THORAX PAIN; WHITE LIGHT ENDOSCOPY;

CRYOTHERAPY; DYSPLASIA; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGECTOMY; INTESTINAL METAPLASIA; RADIOFREQUENCY ABLATION;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CATHETER ABLATION; CRYOSURGERY; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; HUMANS; NEOPLASM STAGING;

EID: 84887031806     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2013.07.010     Document Type: Review

References (48)

1. Sampliner R.E. Practice guidelines on the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 1998, 93:1028-1031.
2. Jung K.W., Talley N.J., Romero Y., et al. Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study. Am J Gastroenterol 2011, 106:1447-1455.
3. Solaymani-Dodaran M., Logan R.F., West J., et al. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 2004, 53:1070-1074.
4. Hvid-Jensen F., Pedersen L., Drewes A.M., et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. NEngl J Med 2011, 365:1375-1383.
5. Hur C., Miller M., Kong C.Y., et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer 2013, 119(6):1149-1158.
6. Goldblum J.R. Barrett's esophagus and Barrett's-related dysplasia. Mod Pathol 2003, 16:316-324.
7. Corley D.A., Levin T.R., Habel L.A., et al. Surveillance and survival in Barrett's adenocarcinoma: a population based study. Gastroenterology 2002, 122:633-640.
8. Fountoulakis A., Zafirellis K., Donlan K., et al. Effect of surveillance of Barrett's oesophagus on clinical outcome of oesophageal cancer. Br J Surg 2004, 91:997-1003.
9. Spechler S.J., Sharma P., Souza R.F., et al. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011, 140:1084-1091.
10. Evans J.A., Early D.S., Fukami N., et al. The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc 2012, 76:1087-1094.
11. Wang K.K., Sampliner R.E. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008, 103:788-797.
12. Bennett C., Vakil N., Bergman J., et al. Consensus statements for management of Barrett's dysplasia and early stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2012, 143:336-346.
13. Fernando H.C., Murthy S.C., Hofstetter W., et al. The Society of Thoracic Surgeons practice guideline series: guidelines for the management of Barrett's esophagus with high-grade dysplasia. Ann Thorac Surg 2009, 87:1993-2002.
14. Rastogi A., Puli S., El-Serag H.B., et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 2008, 67:394-398.
15. Shaheen N.J., Sharma P., Overholt B.F., et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. NEngl J Med 2009, 360:2277-2288.
16. Konda V.J., Ross A.S., Ferguson M.K., et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated?. Clin Gastroenterol Hepatol 2008, 6:159-164.
17. Gupta N., Gaddam S., Wani S.B., et al. Longer inspection time is associated with increase detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett's esophagus. Gastrointest Endosc 2012, 76:531-538.
18. Panossian A.M., Raimondo M., Wolfsen H.C. State of the art in the endoscopic imaging and ablation of Barrett's esophagus. Dig Liver Dis 2011, 43:365-373.
19. Endoscopic Classification Review Group Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005, 37:570-578.
20. May A., Günter E., Roth F., et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 2004, 53:634-640.
21. Young P.E., Gentry A.B., Acosta R.D., et al. Endoscopic ultrasound does not accurately stage early adenocarcinoma or high-grade dysplasia of the esophagus. Clin Gastroenterol Hepatol 2010, 8:1037-1041.
22. Shami V.M., Villaverde A., Stearns L., et al. Clinical impact of conventional endosonography and endoscopic ultrasound-guided fine needle aspiration in the assessment of patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma who have been referred for endoscopic ablation therapy. Endoscopy 2006, 38:157-161.
23. Moss A., Bourke M.J., Hourigan L.F., et al. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit. Am J Gastroenterol 2010, 105:1276-1283.
24. Peters F.P., Brakenhoff K.P., Curvers W.L., et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus. Gastrointest Endosc 2008, 67:604-609.
25. Dunbar K.B., Spechler S.J. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review. Am J Gastroenterol 2012, 107:850-862.
26. Enestvedt B.K., Ginsberg G.G. Advances in endoluminal therapy for esophageal cancer. Gastrointest Endosc Clin N Am 2013, 23:17-39.
27. Shaheen N.J., Overholt B.F., Sampliner R.E., et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 2011, 141:460-468.
28. Ganz R.A., Overholt B.F., Sharma V.K., et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. multicenter registry. Gastrointest Endosc 2008, 68:35-40.
29. Fleischer D.E., Overholt B.F., Sharma V.K., et al. Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy 2010, 42:781-789.
30. Lyday W.D., Corbett F.S., Kuperman D.A., et al. Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy 2010, 42:272-278.
31. Bulsiewicz W.J., Kim H.P., Dellon E.S., et al. Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett's esophagus. Clin Gastroenterol Hepatol 2013, 11(6):636-642.
32. Vaccaro B.J., Gonzalez S., Poneros J.M., et al. Detection of intestinal metaplasia after successful eradication of Barrett's esophagus with radiofrequency ablation. Dig Dis Sci 2011, 56:1996-2000.
33. Orman E.S., Kim H.P., Bulsiewicz W.J., et al. Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett's esophagus with radiofrequency ablation. Am J Gastroenterol 2013, 108(2):187-195.
34. Titi M., Overhiser A., Ulusarac O., et al. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus. Gastroenterology 2012, 143:564-566.
35. Greenwald B.D., Dumot J.A. Cryotherapy for Barrett's esophagus and esophageal cancer. Curr Opin Gastroenterol 2011, 27:363-367.
36. Shaheen N.J., Greenwald B.D., Peery A.F., et al. Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 2010, 71:680-685.
37. Greenwald B.D., Dumot J.A., Abrams J.A., et al. Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc 2010, 71:686-693.
38. Pech O., Bollschweiler E., Manner H., et al. Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Ann Surg 2011, 254(1):67-72.
39. Pech O., Behrens A., May A., et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008, 57(9):1200-1206.
40. Manner H., Pech O., Heldmann Y., et al. Efficacy, safety, and long-term results of endoscopic treatment for early-stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol 2013, 11(6):630-635.
41. Lee L., Ronellenfitsch U., Hofstetter W.L., et al. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system. JAm Coll Surg 2013, 217(2):191-199.
42. Pouw R.E., van Vilsteren F.G., Peters F.P., et al. Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett's neoplasia. Gastrointest Endosc 2011, 74(1):35-43.
43. Alvarez Herrero L., Pouw R.E., van Vilsteren F.G., et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy 2010, 42(12):1030-1036.
44. May A., Gossner L., Pech O. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's esophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002, 14:1085-1091.
45. Pouw R.E., Wirths K., Eisendrath P., et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol 2010, 8:23-29.
46. Kim H.P., Bulsiewicz W.J., Cotton C.C., et al. Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. Gastrointest Endosc 2012, 76:733-739.
47. Van Vilsteren F.G., Pouw R.E., Seewald S., et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicenter randomized trial. Gut 2011, 60:765-773.
48. Zehetner J., DeMeester S.R., Hagen J.A., et al. Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma. JThorac Cardiovasc Surg 2011, 141:39-47.